These results show that interaction of VLA-4 and VCAM-1 receptors on A2058 metastatic melanoma cells and endothelial cells, respectively, is sufficient to disrupt VE-cadherin interactions on adjacent endothelial cells to compromise the endothelial barrier. The gene discussed is CDH5; the disease is metastatic melanoma.